Covered recipient · General Payments record
RYAN JOHN WISE
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$1,777.30
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $387.28 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alcon Laboratories Inc | $115.48 | 5 |
| Bausch & Lomb Americas Inc. | $68.29 | 3 |
| ABBVIE INC. | $55.70 | 2 |
| Amgen Inc. | $55.41 | 2 |
| Sight Sciences, Inc. | $47.79 | 2 |
| Thea Pharma Inc. | $44.61 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.12 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106349980 | CMS |
| ABBVIE INC. | $32.58 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106349982 | CMS |
| Alcon Vision LLC | $18.71 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110678039 | CMS |
| Alcon Vision LLC | $24.23 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110678043 | CMS |
| Alcon Vision LLC | $22.03 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110678041 | CMS |
| Alcon Vision LLC | $24.44 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110678045 | CMS |
| Alcon Vision LLC | $26.07 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110678047 | CMS |
| Amgen Inc. | $27.10 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116211947 | CMS |
| Amgen Inc. | $28.31 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116211949 | CMS |
| Bausch & Lomb Americas Inc. | $25.65 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140441170 | CMS |
| Bausch & Lomb Americas Inc. | $19.50 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140441172 | CMS |
| Bausch & Lomb Americas Inc. | $23.14 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140441174 | CMS |
| Sight Sciences, Inc. | $24.97 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151930535 | CMS |
| Sight Sciences, Inc. | $22.82 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151930533 | CMS |
| Thea Pharma Inc. | $13.07 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074545743 | CMS |
| Thea Pharma Inc. | $15.42 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074545745 | CMS |
| Thea Pharma Inc. | $16.12 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1074545747 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.